Epilepsy cohort questions the added benefit of one pre-implant mapping step

A cohort study in October's Epilepsia examines whether stereo-EEG-guided targeting improves outcomes after responsive neurostimulation. Researchers reviewed 99 patients and compared propensity-matched groups with and without prior stereo-EEG monitoring.

The analysis did not find a statistically significant difference in seizure reduction associated with the additional mapping step. That is relevant because the procedure adds time and complexity to an already demanding treatment pathway.

The study is retrospective, and matching cannot remove every source of selection bias. Its result does not show that stereo-EEG is unnecessary for every patient; it questions an assumed outcome benefit that needs clearer prospective evidence.